feed,title,long_url,short_url
ğŸ”MarketWatch,HealthEquity price target lifted to $75 from $70 at Raymond James,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=HQY&siteid=rss,https://on.mktw.net/300UNkv
ğŸ”MarketWatch,Model N price target boosted to $35 from $30 at Truist Securities,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=MODN&siteid=rss,https://on.mktw.net/3EUuf3L
ğŸ”MarketWatch,N-able price target upped to $12 from $11 at Needham,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=NABL&siteid=rss,https://on.mktw.net/3RV4wOD
ğŸ”MarketWatch,Point Biopharma Global price target hiked to $22 from $20 at Guggenheim,http://www.marketwatch.com/tools/quotes/quotes.asp?symb=PNT&siteid=rss,https://on.mktw.net/3SdSoZt
ğŸ”MarketWatch,World Anti-Doping Agency to keep cannabis on list of banned substances: WSJ,http://www.marketwatch.com/news/story/world-anti-doping-agency-keep-cannabis/story.aspx?guid=%7BFE3A54C4%2D61FD%2D49E9%2DB915%2DE98F67CDA7B6%7D&siteid=rss,https://on.mktw.net/3SdSosr
ğŸ”MarketWatch,Moderna says Japan regulator has approved partial change to NDA for its omicron-targeting COVID booster,http://www.marketwatch.com/news/story/moderna-says-japan-regulator-has/story.aspx?guid=%7B132D5DFF%2D6975%2D4C94%2D9DC3%2D1262F69F6F79%7D&siteid=rss,https://on.mktw.net/3Dfu8Sn
ğŸ”MarketWatch,Ge confirms on track for spinoff of GE HealthCare the first week of Jan. 2023,http://www.marketwatch.com/news/story/ge-confirms-track-spinoff-ge/story.aspx?guid=%7B14A96983%2DDEB1%2D46C1%2D86B0%2D09145C513B9D%7D&siteid=rss,https://on.mktw.net/3Dip13H
